Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |